Jeffcoat Marjorie K, Hauth John C, Geurs Nico C, Reddy Michael S, Cliver Suzanne P, Hodgkins Pamela M, Goldenberg Robert L
University of Alabama at Birmingham School of Dentistry, Birmingham, AL, USA.
J Periodontol. 2003 Aug;74(8):1214-8. doi: 10.1902/jop.2003.74.8.1214.
Previous case-control and prospective studies have shown an association between the presence of periodontitis and the risk of preterm birth (PTB). The goal of this pilot trial was to determine the feasibility of conducting a trial to determine whether treatment of periodontitis reduces the risk of spontaneous preterm birth (SPTB).
Three hundred sixty-six (366) women with periodontitis between 21 and 25 weeks' gestation were recruited and randomized to one of three treatment groups with stratification on the following two factors: 1) previous SPTB at <35 weeks and 2) body mass index <19.8 or bacterial vaginosis as assessed by Gram stain. The treatment groups consisted of: 1) dental prophylaxis plus placebo capsule; 2) scaling and root planing (SRP) plus placebo capsule; and 3) SRP plus metronidazole capsule (250 mg t.i.d. for one week). An additional group of 723 pregnant women meeting the same criteria for periodontitis and enrolled in a prospective study served as an untreated reference group.
The rate of PTB at <35 weeks was 4.9% in the prophylaxis group, compared to 3.3% in the SRP plus metronidazole group and 0.8% in the SRP plus placebo group (P = 0.75 and 0.12, respectively). The rate of PTB at <35 weeks was 6.3% in the reference group.
This trial indicates that performing SRP in pregnant women with periodontitis may reduce PTB in this population. Adjunctive metronidazole therapy did not improve pregnancy outcome. Larger trials will be needed to achieve statistical significance, especially at less than 35 weeks gestational age.
既往病例对照研究和前瞻性研究表明,牙周炎的存在与早产风险之间存在关联。本试点试验的目的是确定开展一项试验以确定牙周炎治疗是否能降低自发性早产(SPTB)风险的可行性。
招募了366名妊娠21至25周的牙周炎女性,并根据以下两个因素分层随机分为三个治疗组之一:1)既往<35周的SPTB;2)体重指数<19.8或革兰氏染色评估的细菌性阴道病。治疗组包括:1)牙齿预防加安慰剂胶囊;2)龈下刮治术和根面平整术(SRP)加安慰剂胶囊;3)SRP加甲硝唑胶囊(250毫克,每日三次,共一周)。另外一组723名符合相同牙周炎标准并参加前瞻性研究的孕妇作为未治疗的参考组。
预防组<35周的早产率为4.9%,SRP加甲硝唑组为3.3%,SRP加安慰剂组为0.8%(P值分别为0.75和0.12)。参考组<35周的早产率为6.3%。
该试验表明,对患有牙周炎的孕妇进行SRP可能会降低该人群的早产率。甲硝唑辅助治疗并未改善妊娠结局。需要进行更大规模的试验以达到统计学显著性,尤其是在孕周小于35周时。